Manganese carbonate nanoparticles-mediated mitochondrial dysfunction for enhanced sonodynamic therapy

Area of Science:

• Biomedical Engineering
• Materials Science
• Oncology

Background:

• Sonodynamic therapy (SDT) is a promising non-invasive cancer treatment leveraging ultrasound. Developing efficient sonosensitizers remains a key challenge for improving therapeutic outcomes.
• Current research focuses on novel nanomaterials for enhanced reactive oxygen species (ROS) generation and targeted drug delivery in SDT.

Purpose of the Study:

• To develop and evaluate manganese carbonate nanoparticles (MnCO3 NPs) as a novel, efficient sonosensitizer for enhanced sonodynamic tumor therapy.
• To investigate the mechanisms of MnCO3 NPs in generating ROS, inducing cell death, and their potential for ultrasound imaging.

Main Methods:

• Synthesis of manganese carbonate nanoparticles (MnCO3 NPs) via a simple method.
• Evaluation of MnCO3 NPs' sonodynamic properties, including 1O2 and •OH generation under ultrasound irradiation.
• Assessment of MnCO3 NPs' degradability in acidic environments and release of CO2 and Mn ions.
• In vitro studies on cell necrosis and apoptosis induction.
• In vivo experiments to assess tumor inhibition rates and therapeutic efficacy.

Main Results:

• MnCO3 NPs efficiently generate large amounts of 1O2 and •OH under ultrasound, enhancing sonodynamic effects.
• Degradation of MnCO3 NPs in weak acidic environments releases CO2 bubbles, causing ultrasonic cavitation-induced cell necrosis and enabling ultrasound imaging.
• Released Mn ions activate the mitochondrial apoptosis pathway, contributing to tumor cell death.
• In vivo studies demonstrated significant tumor inhibition rates, confirming the efficacy of MnCO3 NPs for enhanced sonodynamic tumor therapy.

Conclusions:

• Manganese carbonate nanoparticles (MnCO3 NPs) represent a novel and effective sonosensitizer for enhanced sonodynamic tumor therapy.
• The dual-action mechanism involving ROS generation, ultrasonic cavitation, and mitochondrial apoptosis activation contributes to high therapeutic efficiency.
• MnCO3 NPs show great potential for non-invasive cancer treatment, combining therapeutic effects with diagnostic capabilities.